Probabilities of death from breast cancer and other causes among female breast cancer patients

Journal of the National Cancer Institute

Volumn 96, Issue 17, 2004, Pages 1311-1321

  Schairer, Catherine ^a   Mink, Pamela J ^b   Carroll, Leslie ^c   Devesa, Susan S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b EXPONENT INC   (United States)

^c INFORMATION MANAGEMENT SERVICES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER PATIENT; CAUCASIAN; CAUSE OF DEATH; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; NEGRO; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; RACE DIFFERENCE; RISK ASSESSMENT; STATISTICAL ANALYSIS; TUMOR LOCALIZATION; TUMOR VOLUME; UNITED STATES; VITAL STATISTICS; AFRICAN AMERICAN; AGE DISTRIBUTION; BREAST TUMOR; CANCER REGISTRY; CANCER STAGING; CHEMISTRY; ETHNOLOGY; MIDDLE AGED; MORTALITY; PAGET NIPPLE DISEASE; PATHOLOGY; RISK FACTOR; STATISTICS;

ADULT; AFRICAN AMERICANS; AGE DISTRIBUTION; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CAUSE OF DEATH; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PROBABILITY; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SEER PROGRAM; UNITED STATES;

EID: 4444315066     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djh253     Document Type: Article

References (36)

1. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, et al. (editors). SEER cancer statistics review, 1975-2000. Bethesda (MD): National Cancer Institute; 2003. Available at: http://seer.cancer.gov/csr/1975_2000. [Last accessed: July 13, 2004.]
2. Cronin KA, Feuer EJ. Cumulative cause-specific mortality for cancer patients in the presence of other causes: a crude analogue of relative survival. Stat Med 2000;19:1729-40.
3. Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 and older. JAMA 2001;285:885-92.
4. McGee D, Cooper R, Liao Y, Durazo-Arvizu R. Patterns of comorbidity and mortality risk in blacks and whites. Ann Epidemiol 1996;6:381-5.
5. Wong MD, Shapiro MF, Boscardin WJ, Ettner SL. Contribution of major diseases to disparities in mortality. N Engl J Med 2002;347:1585-92.
6. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst 2001;93:979-89.
7. Diab SG, Elledge RM, Clark GM. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 2000;92: 550-6.
8. Eley JW, Hill HA, Chen VW, Austin DF, Wesley MN, Muss HB, et al. Racial differences in survival from breast cancer. JAMA 1994;272:947-54.
9. Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 1994;120:104-10.
10. West DW, Satariano WV, Ragland DR, Hiatt RA. Comorbidity and breast cancer survival: a comparison between black and white women. Ann Epidemiol 1996;6:413-9.
11. SEER Program: comparative staging guide for cancer. Bethesda (MD): National Institutes of Health. NIH publication No. 93-3640, 1993.
12. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999;18:695-706.
13. Pepe MS, Mori M. Kaplan-Meier. Marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med 1993; 12:737-51.
14. Fish EB, Chapman JW, Link MA. Competing causes of death for primary breast cancer. Ann Surg Oncol 1998;5:368-75.
15. Basche M, Byers T. Re: Tumor characteristics and clinical outcome of elderly women with breast cancer [letter]. J Natl Cancer Inst 2001;93:64-5.
16. Hebert-Croteau N, Brisson J, Latreille J, Blanchette C, Deschenes L. Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women. Cancer 1999;85:1104-13.
17. Muss HB. Factors used to select adjuvant therapy of breast cancer in the United States: an overview of age, race, and socioeconomic status. J Natl Cancer Inst Monogr 2001;30:52-5.
18. Du X, Goodwin JS. Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data. J Clin Oncol 2001;19: 1455-61.
19. Welch HG, Albertsen PC, Nease RF, Bubolz TA, Wasson JH. Estimating treatment benefits for the elderly: the effect of competing risks. Ann Intern Med 1996;124:577-84.
20. Lichtman SM. Chemotherapy in the elderly. Semin Oncol 2004;31:160-74.
21. Kemeny MM. Surgery in older patients. Semin Oncol 2004;31:175-84.
22. Joslyn SA, West MM. Racial differences in breast carcinoma survival. Cancer 2000;88:114-23.
23. O'Malley CD, Le GM, Glaser SL, Shema SJ, West DW. Socioeconomic status and breast carcinoma survival in four racial/ethnic groups. Cancer 2003;97:1303-11.
24. Chu KC, Lamar CA, Freeman HP. Racial disparities in breast carcinoma survival rates: separating factors that affect diagnosis from factors that affect treatment. Cancer 2003;97:2853-60.
25. Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 2003;163:49-56.
26. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 2002;94:334-57.
27. Chen VW, Correa P, Kurman RJ, Wu XC, Eley JW, Austin D, et al. Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol Biomarkers Prev 1994;3:127-35.
28. Barnett JB. The relationship between obesity and breast cancer risk and mortality. Nutr Rev 2003;61:73-6.
29. Okosun IS, Choi ST, Boltri JM, Parish DC, Chandra KM, Dever GE, et al. Trends of abdominal adiposity in white, black, and Mexican-American adults, 1988 to 2000. Obesity Res 2003;11:1010-7.
30. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA 2004;291:1238-45.
31. Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM, et al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000;124:966-78.
32. Kircher T, Nelson J, Burdo H. The autopsy as a measure of accuracy of the death certificate. N Engl J Med 1985;313:1263-9.
33. Percy C, Stanek E 3rd, Gloeckler L. Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health 1981;71: 242-50.
34. Percy CL, Miller BA, Gloeckler Ries LA. Effect of changes in cancer classification and the certificates on trends in cancer mortality. Ann N Y Acad Sci 1990;609:87-99.
35. Brinkley D, Haybittle JL, Alderson MR. Death certification in cancer of the breast. BMJ 1984;289:465-7.
36. Welch HG, Black WC. Are deaths within 1 month of cancer-directed surgery attributed to cancer? J Natl Cancer Inst 2002;94:1066-70.